CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,557,449 | -21.1% | 475,402 | -9.3% | 0.01% | -9.1% |
| Q2 2023 | $7,043,608 | -1.4% | 524,078 | +21.7% | 0.01% | -8.3% |
| Q1 2023 | $7,142,116 | -8.1% | 430,767 | +3.1% | 0.01% | -7.7% |
| Q4 2022 | $7,772,828 | +187.9% | 417,894 | +98.5% | 0.01% | +160.0% |
| Q3 2022 | $2,700,000 | -51.0% | 210,482 | -73.2% | 0.01% | -44.4% |
| Q2 2022 | $5,506,000 | -38.4% | 785,564 | -27.1% | 0.01% | -18.2% |
| Q1 2022 | $8,938,000 | +197.5% | 1,078,251 | +143.0% | 0.01% | +266.7% |
| Q4 2021 | $3,004,000 | – | 443,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |